Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “S. Pneumoniae”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT06049134
What this trial is testing

Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06975878
What this trial is testing

Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Who this might be right for
Pneumococcal ImmunizationHealthy Volunteers
Sanofi 1,092
Not applicableStudy completedNCT00273325
What this trial is testing

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Who this might be right for
Pneumococcal InfectionsStreptococcus PneumoniaeInfant, Newborn+3 more
NICHD Neonatal Research Network 368
Not applicableStudy completedNCT02096848
What this trial is testing

Microbiology of Otitis Media in Costarrican Children After PCV13 Introduction

Who this might be right for
Otitis Media in Children
Instituto de Atención Pediátrica 387
Testing effectiveness (Phase 2)Study completedNCT02573181
What this trial is testing

Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 253
Large-scale testing (Phase 3)Study completedNCT01964716
What this trial is testing

13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.

Who this might be right for
Pneumococcal Vaccines
Pfizer 500
Early research (Phase 1)Study completedNCT04830358
What this trial is testing

Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults

Who this might be right for
Pneumococcal Disease
EuBiologics Co.,Ltd 60
Large-scale testing (Phase 3)Study completedNCT01692886
What this trial is testing

A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China

Who this might be right for
Pneumococcal Infection
Pfizer 1,674
Not applicableUnknownNCT03064620
What this trial is testing

PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study

Who this might be right for
Streptococcus Pneumoniae
Sheba Medical Center 12,800
Not applicableWithdrawnNCT00001080
What this trial is testing

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Looking for participantsNCT06800261
What this trial is testing

Clinical Trial of PCV24 in Infants Aged 2-23 Months

Who this might be right for
Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd. 180
Not applicableStudy completedNCT06450379
What this trial is testing

Impact of Vaccines on Antimicrobial Microbial Resistance

Who this might be right for
Vaccine
Malawi Liverpool Wellcome Programme 13,200
Testing effectiveness (Phase 2)Study completedNCT03566940
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 302
Testing effectiveness (Phase 2)Study completedNCT00327522
What this trial is testing

Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

Who this might be right for
Prophylactic Pneumococcal Diseases
GlaxoSmithKline 10
Testing effectiveness (Phase 2)Study completedNCT01359150
What this trial is testing

Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo

Who this might be right for
Rheumatoid Arthritis
Pfizer 223
Not applicableStudy completedNCT01861184
What this trial is testing

Pneumococcal Carriage in Patients With Lower Respiratory Tract Infection (LRTI)

Who this might be right for
Lower Respiratory Tract Infections
Liverpool University Hospitals NHS Foundation Trust 38
Very early researchStudy completedNCT07025876
What this trial is testing

PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

Who this might be right for
Streptococcus Pneumoniae Pneumonia
Jiangsu Province Centers for Disease Control and Prevention 240
Post-approval studies (Phase 4)Study completedNCT00581620
What this trial is testing

Study Evaluating Prevenar Immunogenicity in High Risk Children

Who this might be right for
Vaccines, Pneumococcal Conjugate Vaccine
Wyeth is now a wholly owned subsidiary of Pfizer 160
Large-scale testing (Phase 3)Study completedNCT01026038
What this trial is testing

Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.

Who this might be right for
13-valent Pneumococcal VaccineImmunizationSafety+1 more
Pfizer 263
Large-scale testing (Phase 3)Study completedNCT01746108
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae Vaccines
GlaxoSmithKline 52
Next Page